UNITED ~~SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549~~STATES

~~_________________~~SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

~~_________________~~Report of Foreign Private Issuer

~~Report~~Pursuant ~~of Foreign Private IssuerPursuant~~ to Rule 13a-16 or 15d-~~16under the Securities Exchange Act of 1934~~16

~~For~~under the ~~month~~Securities Exchange Act of~~: November 2023~~ 1934

For the month of December 2023

Commission file number: 001-39674

~~_________________~~G MEDICAL INNOVATIONS HOLDINGS LTD.

~~G MEDICAL INNOVATIONS HOLDINGS LTD.~~(Translation of registrant’s name into English)

~~_________________~~5 Oppenheimer St.

~~5 Oppenheimer St.~~Rehovot 7670105, Israel~~(Address of principal executive offices)~~

~~_________________~~(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

CONTENTS

On ~~November 29~~December 15, 2023, ~~G Medical Innovations Holdings Ltd. (the “Company”) announced that it will hold~~ an Extraordinary General Meeting of Shareholders ~~on December 15, 2023~~ (the “Meeting”). ~~Only shareholders~~ of ~~record~~G ~~who~~Medical ~~held~~Innovations ~~ordinary~~Holdings ~~shares, par value $0~~Ltd.~~007~~ ~~per share, of~~ (the “Company”) atwas ~~the close of business on November 22, 2023, will be entitled to notice of and to vote at the Meeting and any postponements or adjournments thereof~~convened.

~~Copies~~At the ofMeeting, a quorum was present and the ~~Notice~~shareholders of ~~Annual~~the ~~General~~Company ~~Meeting,~~voted ~~Proxy~~upon ~~Statement~~ and ~~Form~~approved ofall agenda items that were described in the Company’s Notice and Proxy ~~Card~~Statement for the Meeting, ~~are~~which ~~furnished~~were ~~herewith~~included as ~~Exhibits~~Exhibit 99.1, ~~99.2~~ and Exhibit 99.32, respectively., ~~The~~to the ~~Notice~~Company’s Report of ~~Annual~~Foreign ~~General~~Private ~~Meeting,~~Issuer ~~Proxy~~on ~~Statement~~Form ~~and~~6-K ~~Form~~for the Month of ~~Proxy~~November ~~Card~~2023 ~~for~~that the ~~Meeting~~Company ~~are~~furnished ~~also~~to ~~available~~the onSecurities and Exchange Commission (the ~~Company’s~~“SEC”) ~~website~~on November 28, ~~www~~2023.~~gmedinnovations.com.~~

~~This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the~~ The Company’s ~~Registration~~new ~~Statements~~Amended ~~on Form F-3 (File No. 333-266090)~~ and onRestated ~~Form S-8~~Memorandum ~~(File No. 333-266063~~ and ~~File~~Articles ~~No. 333-273146),~~of ~~filed with the SEC~~Association, towhich bewere aapproved ~~part~~at ~~thereof from~~ the ~~date~~Meeting, onbecame ~~which~~effective immediately ~~this~~following ~~Report is submitted to~~ the ~~extent~~Meeting ~~not~~and ~~superseded~~are byincluded ~~documents~~as orExhibit ~~reports~~3.1 ~~subsequently filed or furnished~~hereto.

Exhibit No.
99.1		Notice of Extraordinary General Meeting of Shareholders.
99.2		Proxy Statement for Extraordinary General Meeting of Shareholders.
99.3		Form of Proxy Card for Extraordinary General Meeting of Shareholders.

This Report of Foreign Private Issuer on Form 6-K (this “Report”) is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-266090) and on Form S-8 (File No. 333-266063 and File No. 333-273146), filed with the SEC, to be a part thereof from the date on which this Report is submitted to the extent not superseded by documents or reports subsequently filed or furnished.

EXHIBIT INDEX

Exhibit No.		Description
3.1		Amended and Restated Memorandum and Articles of Association of G Medical Innovations Holdings Ltd.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		G Medical Innovation Holdings Ltd.
	G Medical Innovations Holdings Ltd.
Date: November 29, 2023		By:		/s/ Yacov Geva
Date: December 18, 2023	By:	/s/ Yacov Geva
		Name:	Yacov Geva	~~Yacov Geva~~
		Title:	Chief Executive Officer	~~Chief Executive Officer~~

Filing Compare · G Medical Innovations Holdings Ltd.